Skip to main content
Premium Trial:

Request an Annual Quote

Solexa Receives 700,000 UK Grant to Co-Develop Comparative Genomics Platform

NEW YORK, March 2 (GenomeWeb News) - Solexa has won more than ₤700,000 ($1.3 million) in funding from the UK government to co-develop a comparative genome analysis platform, the company said last week.


The aim of the project, a collaboration between the European Bioinformatics Institute, Imperial College London, the Wellcome Trust Sanger Institute, and Solexa, is to develop new bioinformatics tools for the comparative analysis of whole genome data. It will include enabling the Ensembl software system to handle whole genome sequences from several individuals, and developing new statistical tools for analyzing whole genome data.


The total budget for the project, expected to start in April, is ₤1.53 million, which includes contributions from Solexa. The company received the government grant under the LINK program from the UK's Department of Trade and Industry and the Medical Research Council.


Solexa, based in Cambridge, UK, is developing technology for the analyzing individual genomes quickly and economically.


The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.